← Issue №18/ week of Nov 1, 2026/IBD

Anemia in inflammatory bowel disease: despite declining rates still a remarkable burden.

From GI Signals issue №18: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

IBD retrospective · n=3,698 · Oct 30, 2026 · Eur J Gastro Hep · IF 2.2

Anemia in inflammatory bowel disease: despite declining rates still a remarkable burden.

New evidenceepidemiologyCrohn's diseaseulcerative colitis
Clinical takeawayAnemia stays common years after diagnosis, especially in women and complex phenotypes, though rates were lower after 2010; the registry does not define a monitoring interval.
What it foundAnemia prevalence in IBD patients was 57% in women and 55% in men at diagnosis, decreasing to 35% in women and 20% in men 5 years post-diagnosis, with significantly lower prevalence in patients diagnosed after 2010 compared to those diagnosed before 2010.
ContextConfirms anemia as a common complication in adults with IBD, with higher prevalence in women and complex phenotypes, and shows a decline over time but persistent burden, particularly in patients diagnosed before 2010.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Ismail A … Af Björkesten CG · European Journal of Gastroenterology & Hepatology · IF 2.2 · PubMed ↗Permalink
← Read the whole of issue №18 Every paper GI Signals surfaces gets a page like this one. All issues